425 related articles for article (PubMed ID: 29521252)
1. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
Yurttaş L; Çiftçi GA
Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumoral evaluation of 7-chloro-4-quinolinylhydrazones derivatives.
Montenegro RC; Lotufo LV; de Moraes MO; Pessoa Cdo Ó; Rodrigues FA; Bispo Mde L; Cardoso LN; Kaiser CR; de Souza MV
Med Chem; 2011 Nov; 7(6):599-604. PubMed ID: 22316343
[TBL] [Abstract][Full Text] [Related]
3. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
5. Sulphonamido-quinoxalines: search for anticancer agent.
Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
El-Gohary NS; Shaaban MI
Eur J Med Chem; 2017 May; 131():255-262. PubMed ID: 28334654
[TBL] [Abstract][Full Text] [Related]
7. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
[TBL] [Abstract][Full Text] [Related]
8. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel benzo- and tetrahydrobenzo-[h]quinoline derivatives as potential DNA-intercalating antitumor agents.
Jafari F; Baghayi H; Lavaee P; Hadizadeh F; Soltani F; Moallemzadeh H; Mirzaei S; Aboutorabzadeh SM; Ghodsi R
Eur J Med Chem; 2019 Feb; 164():292-303. PubMed ID: 30599418
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives.
Othman DIA; Selim KB; El-Sayed MA; Tantawy AS; Amen Y; Shimizu K; Okauchi T; Kitamura M
Bioorg Med Chem; 2019 Oct; 27(19):115026. PubMed ID: 31416740
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives.
Marciniec K; Pawełczak B; Latocha M; Skrzypek L; Maciążek-Jurczyk M; Boryczka S
Molecules; 2017 Feb; 22(2):. PubMed ID: 28212337
[TBL] [Abstract][Full Text] [Related]
15. Development of 2'-aminospiro [pyrano[3,2-c]quinoline]-3'-carbonitrile derivatives as non-ATP competitive Src kinase inhibitors that suppress breast cancer cell migration and proliferation.
Ramadan M; A M M Elshaier Y; Aly AA; Abdel-Aziz M; Fathy HM; Brown AB; Pridgen JR; Dalby KN; Kaoud TS
Bioorg Chem; 2021 Nov; 116():105344. PubMed ID: 34598088
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents.
Ghorab MM; Ragab FA; Hamed MM
Arzneimittelforschung; 2010; 60(3):141-8. PubMed ID: 20422946
[TBL] [Abstract][Full Text] [Related]
17. The activity of pyrazolo[4,3-
Szymanowska A; Radomska D; Czarnomysy R; Mojzych M; Kotwica-Mojzych K; Bielawski K; Bielawska A
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2343352. PubMed ID: 38700244
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents.
Alam MS; Nam YJ; Lee DU
Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and antitumor screening of certain novel tetrahydroquinoline sulfonamides.
Alafeefy AM
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):189-94. PubMed ID: 24666309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]